Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 76 - 100 of 401 in total
Main Class Sub Class ▼ LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Glycosylglycerophospholipids Diacylglycosylglycerophospholipids LMGP1401AB00
  • 2'-[1,2-diacyl-sn-glycero-3-phospho]-3'-alpha-galactosyl-N-glyceroyl-heptadecylamine
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010001
  • EtN-P-6ManAlpha1-2ManAlpha1-6ManAlpha1-4GlcNAlpha1-6-PI(14:0/14:0)
  • EtN-P-6Manalpha1-2Manalpha1-6Manalpha1-4GlcNalpha1-6-PI(14:0/14:0)
73242190 1524.699049 C63H118N2O35P2
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010002
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/14:0)
126457370 944.547358 C45H85O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010003
  • 2'-O-(alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:0)
126457371 972.578658 C47H89O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010004
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:1(9Z))
126457372 970.563008 C47H87O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010005
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:2(9Z,12Z))
126457373 968.547358 C47H85O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010006
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:0)
126457374 1000.609958 C49H93O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010007
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:1(9Z))
126457375 998.594308 C49H91O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010008
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/14:0)
126457376 958.563008 C46H87O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010009
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:0)
126457377 986.594308 C48H91O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010010
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:1(9Z))
126457378 984.578658 C48H89O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010011
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:2(9Z,12Z))
126457379 982.563008 C48H87O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010012
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/18:0)
126457380 1014.625608 C50H95O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010013
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/18:1(9Z))
126457381 1012.609958 C50H93O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010014
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/14:0)
126457382 972.578658 C47H89O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010015
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:0)
126457383 1000.609958 C49H93O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010016
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:1(9Z))
126457384 998.594308 C49H91O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010017
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:2(9Z,12Z))
126457385 996.578658 C49H89O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010018
  • 2'-O-(alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/18:0)
126457386 1028.641258 C51H97O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010019
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/18:1(9Z))
126457387 1026.625608 C51H95O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010020
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/14:0)
126457388 970.563008 C47H87O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010021
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/16:0)
126457389 998.594308 C49H91O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010022
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/16:1(9Z))
126457390 996.578658 C49H89O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010023
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/16:2(9Z,12Z))
126457391 994.563008 C49H87O18P
Glycerophosphoinositolglycans Diacylglycerophosphoinositolglycans LMGP15010024
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/18:0)
126457392 1026.625608 C51H95O18P

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024